Q. Huang

发表

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance

B. Dai, Le Xu, Hongyu Zhang, 2020, Oncoimmunology.

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma

B. Dai, Le Xu, Hongyu Zhang, 2020, Journal for ImmunoTherapy of Cancer.

Intratumoral CCR5+ neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses

B. Dai, Le Xu, Hongyu Zhang, 2020, Oncoimmunology.

Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture

B. Dai, Le Xu, Hongyu Zhang, 2020, Journal for immunotherapy of cancer.

Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin+ cell abundance

B. Dai, Le Xu, Hongyu Zhang, 2020, Oncoimmunology.

Poor clinical outcomes and immunoevasive contexture in interleukin‐9 abundant muscle‐invasive bladder cancer

B. Dai, Le Xu, Hongyu Zhang, 2020, International journal of cancer.

Intratumoral TIGIT+ CD8+ T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer

B. Dai, Le Xu, Hongyu Zhang, 2020, Journal for ImmunoTherapy of Cancer.

Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer

B. Dai, Le Xu, Hongyu Zhang, 2020, Oncoimmunology.

Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients

B. Dai, Le Xu, Hongyu Zhang, 2020, Journal for ImmunoTherapy of Cancer.